IT1312341B1 - 10-Formyltetrahydrofolate dehydrogenase, useful as a therapeutic agent, particularly as an antitumor agent possessing high cytotoxicity - Google Patents

10-Formyltetrahydrofolate dehydrogenase, useful as a therapeutic agent, particularly as an antitumor agent possessing high cytotoxicity

Info

Publication number
IT1312341B1
IT1312341B1 ITMI991243A IT1312341B1 IT 1312341 B1 IT1312341 B1 IT 1312341B1 IT MI991243 A ITMI991243 A IT MI991243A IT 1312341 B1 IT1312341 B1 IT 1312341B1
Authority
IT
Italy
Prior art keywords
useful
therapeutic agent
possessing high
high cytotoxicity
formyltetrahydrofolate dehydrogenase
Prior art date
Application number
Other languages
Italian (it)
Inventor
Alberto Bartorelli
Original Assignee
Pharmaproducts Uk Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmaproducts Uk Ltd filed Critical Pharmaproducts Uk Ltd
Publication of ITMI991243A0 publication Critical patent/ITMI991243A0/en
Priority to IT99MI001243 priority Critical patent/IT1312341B1/en
Priority to EP00945698A priority patent/EP1181046B1/en
Priority to AT00945698T priority patent/ATE247976T1/en
Priority to JP2001501245A priority patent/JP2003501398A/en
Priority to AU59695/00A priority patent/AU5969500A/en
Priority to PCT/EP2000/005066 priority patent/WO2000074711A2/en
Priority to DE60004819T priority patent/DE60004819T2/en
Priority to ES00945698T priority patent/ES2204649T3/en
Publication of ITMI991243A1 publication Critical patent/ITMI991243A1/en
Application granted granted Critical
Publication of IT1312341B1 publication Critical patent/IT1312341B1/en

Links

Landscapes

  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The use of 10-formyltetrahydrofolate dehydrogenase (I) as a therapeutic agent, is new. ACTIVITY : Cytostatic. MECHANISM OF ACTION : Cytotoxicity is mediated by cytotoxic antibodies to human tumor cells, particularly carcinomas and adenocarcinomas.
IT99MI001243 1999-06-03 1999-06-03 10-Formyltetrahydrofolate dehydrogenase, useful as a therapeutic agent, particularly as an antitumor agent possessing high cytotoxicity IT1312341B1 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
IT99MI001243 IT1312341B1 (en) 1999-06-03 1999-06-03 10-Formyltetrahydrofolate dehydrogenase, useful as a therapeutic agent, particularly as an antitumor agent possessing high cytotoxicity
AU59695/00A AU5969500A (en) 1999-06-03 2000-06-02 10-formyltetrahydrofolate dehydrogenase as therapeutical agent
AT00945698T ATE247976T1 (en) 1999-06-03 2000-06-02 10-FORMYLTETRAHYDROFOLATE DEHYDROGENASE AS A THERAPEUTIC AGENT
JP2001501245A JP2003501398A (en) 1999-06-03 2000-06-02 10-formyltetrahydrofolate dehydrogenase as therapeutic agent
EP00945698A EP1181046B1 (en) 1999-06-03 2000-06-02 10-formyltetrahydrofolate dehydrogenase as therapeutical agent
PCT/EP2000/005066 WO2000074711A2 (en) 1999-06-03 2000-06-02 10-formyltetrahydrofolate dehydrogenase as therapeutical agent
DE60004819T DE60004819T2 (en) 1999-06-03 2000-06-02 10-FORMYLTETRAHYDROFOLATE DEHYDROGENASE AS A THERAPEUTIC AGENT
ES00945698T ES2204649T3 (en) 1999-06-03 2000-06-02 `10-FORMILTETRAHYDROPHOLATE DEHYDROGENASE AS A THERAPEUTIC AGENT.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT99MI001243 IT1312341B1 (en) 1999-06-03 1999-06-03 10-Formyltetrahydrofolate dehydrogenase, useful as a therapeutic agent, particularly as an antitumor agent possessing high cytotoxicity

Publications (3)

Publication Number Publication Date
ITMI991243A0 ITMI991243A0 (en) 1999-06-03
ITMI991243A1 ITMI991243A1 (en) 2000-12-03
IT1312341B1 true IT1312341B1 (en) 2002-04-15

Family

ID=11383109

Family Applications (1)

Application Number Title Priority Date Filing Date
IT99MI001243 IT1312341B1 (en) 1999-06-03 1999-06-03 10-Formyltetrahydrofolate dehydrogenase, useful as a therapeutic agent, particularly as an antitumor agent possessing high cytotoxicity

Country Status (1)

Country Link
IT (1) IT1312341B1 (en)

Also Published As

Publication number Publication date
ITMI991243A1 (en) 2000-12-03
ITMI991243A0 (en) 1999-06-03

Similar Documents

Publication Publication Date Title
GEP20094798B (en) (s,s)-reboxetine for treating chronic pain
CY1112753T1 (en) HUMAN BODY CANCER TREATMENT BY USE TO743
GB9814172D0 (en) Formulation for inhalation
MY124853A (en) 4-amino-5-phenyl-7-cyclobutyl-pyrrolo[2,3-d]pyrimidine derivatives.
AU1221297A (en) Ultra sound method
WO2001024763A3 (en) Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
PL365285A1 (en) Pharmaceutical combinations for the treatment of cancer comprising dioxolane nucleoside analogs
IL155781A0 (en) Effective antitumor treatments
EP1259240B8 (en) Agents, such as nicotinamide or cadpr for the treatment of skin disorders
WO2001026704A3 (en) Targeted drug activation
AU2001247968A1 (en) Use of asiatic acid or asiaticoside for treatment of cancer
WO2000008651A3 (en) Palladium coated implant
PT1390007E (en) Cosmetic composition based on zinc and copper sulphates and sucralphate
AU2002332488A8 (en) R-bambuterol, its preparation and therapeutic uses
WO2004007676A3 (en) Combination therapy for the treatment of neoplasms
IT1314197B1 (en) 10-Formyltetrahydrofolate dehydrogenase, useful as a therapeutic agent, particularly as an antitumor agent possessing high cytotoxicity
IT1312341B1 (en) 10-Formyltetrahydrofolate dehydrogenase, useful as a therapeutic agent, particularly as an antitumor agent possessing high cytotoxicity
WO2004078126A3 (en) Compositions and methods with enhanced therapeutic activity
IL131478A0 (en) Methods for treatment of scar tissue
IL159770A0 (en) Calcium salts with cytotoxic activity
NZ515173A (en) Treatment of hypersensitivity reaction disorders
NZ506406A (en) Compositions comprising Mycobacterium phlei DNA and methods for its use in the treatment of bladder cancer
AU2003281257A1 (en) A novel use of rapamycin and structural analogues thereof
WO2003072019A3 (en) Sequential therapy comprising a 20(s)-camptothecin compound and a pyrimidine base analog
IL157408A (en) Use of elemental calcium in the manufacture of a medicament to reduce prostate cancer risk